Hillsdale Investment Management’s NeoGenomics NEO Stock Holding History

Hillsdale Investment Management’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-300	Closed	-$3.69K	–	617
2023 Q3	$3.69K	Sell	300 -250,400	-100%	-$3.72M	﹤0.01%	550
2023 Q2	$4.03M	Sell	250,700 -67,300	-21%	-$1.11M	0.37%	111
2023 Q1	$5.54M	Buy	+318,000	New	+$4.53M	0.47%	67
2019 Q1	–	Sell	-32,900	Closed	-$415K	–	657
2018 Q4	$415K	Buy	+32,900	New	+$490K	0.05%	310

Other funds holding NEO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Hillsdale Investment Management's NEO Position: Q4 2023 in Review

Hillsdale Investment Management sold out of NeoGenomics (NEO) in Q4 2023, closing a stake of 300 shares — an estimated $3.69K sold.

Hillsdale Investment Management first reported a position in NEO in Q4 2018 and held it in 4 quarters. The position peaked at $5.54M in Q1 2023. 287 funds tracked by Wall St. Rank hold NEO as of Q4 2023.

Hillsdale Investment Management reported no remaining NeoGenomics position as of Q4 2023 after selling out during the quarter.
Hillsdale Investment Management sold 300 NeoGenomics shares in Q4 2023, an estimated $3.69K.
Hillsdale Investment Management first reported a position in NeoGenomics in Q4 2018 and held it in 4 quarters.
Hillsdale Investment Management's NeoGenomics position peaked at $5.54M in Q1 2023.
287 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2023.

Based on Hillsdale Investment Management's 13F filing for Q4 2023, filed 9 Feb 2024.